These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15464074)

  • 21. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.
    Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M
    J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of erythromycin on the pharmacokinetics of ximelagatran may involve inhibition of P-glycoprotein-mediated excretion.
    Eriksson UG; Dorani H; Karlsson J; Fritsch H; Hoffmann KJ; Olsson L; Sarich TC; Wall U; Schützer KM
    Drug Metab Dispos; 2006 May; 34(5):775-82. PubMed ID: 16455803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats.
    Hasegawa T; Nadai M; Wang L; Takayama Y; Kato K; Nabeshima T; Kato N
    Drug Metab Dispos; 1994; 22(1):8-13. PubMed ID: 8149895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
    Lin JH; Chen IW; deLuna FA; Hichens M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):670-5. PubMed ID: 8246140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of renal excretion between nilvadipine metabolites, M3 and M7 in rats: characterization of sex-dependent and sex-independent active secretion in the kidney.
    Terashita S; Sawamoto T; Tozuka Z; Tokuma Y; Hata T
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):205-15. PubMed ID: 7881869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats.
    Hayashi T; Abe F; Kato M; Saito H; Ueyama J; Kondo Y; Imai K; Katoh M; Nadai M; Hasegawa T
    J Infect Chemother; 2011 Feb; 17(1):24-9. PubMed ID: 20676911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    Drug Metab Dispos; 1993; 21(4):611-6. PubMed ID: 8104119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.
    Suzuki T; Zhao YL; Nadai M; Naruhashi K; Shimizu A; Takagi K; Takagi K; Hasegawa T
    Life Sci; 2006 Jun; 79(5):455-61. PubMed ID: 16483613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of phase I metabolic enzyme activities in liver microsomes of Mrp2 deficient TR- and EHBR rats.
    Newton DJ; Wang RW; Evans DC
    Life Sci; 2005 Jul; 77(10):1106-15. PubMed ID: 15913659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectroscopic studies on the interaction of pazufloxacin with calf thymus DNA.
    Ling X; Zhong W; Huang Q; Ni K
    J Photochem Photobiol B; 2008 Dec; 93(3):172-6. PubMed ID: 18945625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride].
    Matsumoto S; Yoshida K; Ishiguro N; Maeda T; Tamai I
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1246-52. PubMed ID: 17556638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of renal failure on drug transport and metabolism.
    Sun H; Frassetto L; Benet LZ
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
    Bolzati C; Cavazza-Ceccato M; Agostini S; Tokunaga S; Casara D; Bandoli G
    J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats.
    Hayakawa H; Takagi K; Takano YF; Kawamura Y; Tsuji A
    J Pharm Pharmacol; 2002 Sep; 54(9):1229-36. PubMed ID: 12356277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR).
    Takada Y; Tachizawa H; Kurihara H; Takayanagi M; Sasamoto T; Akashi M; Aiso M; Takamori Y; Sano N; Takikawa H
    J Hepatobiliary Pancreat Surg; 2004; 11(2):125-8. PubMed ID: 15127276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.